Saturday, July 11, 2026

Drug profile · INN

morphine

morphine (MORPHINE JUNO) is a mu opioid receptor agonist. Associated with Lacuna Pharma Pty Ltd.

TGA: approved
Patents linked 14
Pipeline programs 27
News articles 0
Drug details — morphine

Quick answer

morphine (MORPHINE JUNO) is a mu opioid receptor agonist. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN morphine
Brand MORPHINE JUNO
Mechanism Mu opioid receptor agonist

Mechanism of action

Mu opioid receptor agonist

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. APHP 180610 Phase 3 · PARItec · Acute Myocardial Infarction
  2. APHP 180610 Phase 3 · PARItec · Acute Myocardial Infarction
  3. APHP 230842 Phase 3 · PARItec · patients with chronic respiratory insufficiency due to amyot
  4. APHP211035 Phase 3 · PARItec · vaso-occlusive crisis due to sickle cell disease
  5. APHP211044 Phase 3 · PARItec · urgency, limb injuries
  6. apomorphine infusion Phase 3 · SUPERNUS PHARMACEUTICALS · Idiopathic Parkinson's Disease
  7. Morphine Phase 2 · Hospital Authority · Respiratory Depression
  8. DepoDur (extended-release epidural morphine) Phase 1 · Pacira Ireland · Postoperative Pain
  1. US 12383625

    Polyoxazoline-drug conjugates with novel pharmacokinetic properties

    Expires 2045-08-07T00:00:00.000Z

    granted
  2. US 12383626

    Polyoxazoline-drug conjugates with novel pharmacokinetic properties

    Expires 2045-08-07T00:00:00.000Z

    granted
  3. US 12233132

    Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same

    Expires 2045-02-20T00:00:00.000Z

    granted
  4. US 11925689

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires 2044-03-07T00:00:00.000Z

    granted
  5. US 11213588

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires 2041-12-30T00:00:00.000Z

    granted
  6. US 10864276

    Activated polyoxazolines and conjugates and compositions comprising the same

    Expires 2040-12-10T00:00:00.000Z

    granted
  7. US 10166294

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires 2038-12-27T00:00:00.000Z

    granted
  8. US 10086084

    Activated polyoxazolines and conjugates and compositions comprising the same

    Expires 2038-09-27T00:00:00.000Z

    granted
  9. US 9169354

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires 2035-10-22T00:00:00.000Z

    granted
  10. US 8501899

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires 2033-08-01T00:00:00.000Z

    granted
  11. US 8110651

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires 2032-02-02T00:00:00.000Z

    granted
  12. US 8101706

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires 2032-01-19T00:00:00.000Z

    granted
  13. US 8088884

    Multi-armed forms of activated polyoxazoline and methods of synthesis thereof

    Expires 2031-12-29T00:00:00.000Z

    granted
  14. US 7943141

    Activated polyoxazolines and compositions comprising the same

    Expires 2031-05-12T00:00:00.000Z

    granted

Frequently asked questions

What is morphine?

morphine (MORPHINE JUNO) is a mu opioid receptor agonist. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for morphine?

MORPHINE JUNO is a marketed brand name for morphine. Check FDA Drugs@FDA for the current US label holder and prescribing information.